2021 Annual Meeting - Treating the Toxicity: Survivorship following Head and Neck Cancer Radiotherapy

As the worldwide incidence of head and neck cancer increases, so do the sequelae of the treatments provided. Multidisciplinary and individualized management of treatment related sequelae is essential and parallels the ASTRO theme of “Advancing Person-Centered Care.” This educational session will bring together experts to provide practical guidance on the diagnosis and mitigation of dysphagia, lymphedema, mucositis, and depression in head and neck cancer patients who have received radiation therapy.

Dr. Patricia Corby (UPenn) will focus on the optimization of the oral microbiome during/after radiation. Ms. Heather Starmer (Stanford) will describe contemporary strategies addressing dysphagia and lymphedema management. Dr. William Lydiatt (Creighton), a leader of the Prevention of Depression in Patients Being Treated for Head and Neck Cancer Trial (PROTECT) study group, will discuss the diagnosis and management of depression in the head and neck cancer population.

All clinicians who participate in head and neck cancer treatment must remain current regarding the best strategies to manage swallowing and oral care. The topic of depression is understudied in our patients and underrepresented at ASTRO however, it remains a significant challenge, exacerbated by COVID19 and closely aligned with the 2021 ASTRO theme. The addition of a patient’s experience will provide an important context for the problems as well as the practical tips discussed.

The goal of this session, consistent with ASTRO’s theme of advancing person-center care with new approaches, is to identify challenges after head and neck radiation therapy and posit constructive and practical solutions about how to address them. 

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, surgeons, nurses and medical oncologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify depression in head and neck cancer patients, treat, and refer when appropriate.
  • Explain the diagnosis of dysphagia, and advise the patient on practical strategies to improve food intake.
  • Discuss appropriate strategies to maintain oral hygiene and swallowing after head and neck radiotherapy.
Course summary
Available credit: 
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
  • 1.25 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

Course opens: 
08/23/2021
Course expires: 
11/30/2021
Cost:
$0.00
Rating: 
0
  • Patricia Corby, University of Pennsylvania School of Dental Medicine and has no financial relationships with a commercial interest.
  • William M. Lydiatt, University of Nebraska Medical Center College of Medicine and Nebraska Methodist Hospital and Creighton University and receives compensation from Best Doctors.
  • Heather Starmer, MS, Stanford University and has no financial relationships with a commercial interest.
  • Maureen Katz, MD, N/A - What I Wish I Had Known About Head and Neck Cancer Treatment and has no financial relationships with a commercial interest.

The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

Disclosure link: 
Committee Disclosures

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
  • 1.25 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

Price

Cost:
$0.00
Please login or register to take this course.

Policies: 
    • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
    • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
    • ASTRO staff cannot make modifications to your submitted materials.
 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.